- E78.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E78.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E78.1 – other international versions of ICD-10 E78.1 may differ.
ICD-10-CM E78.1 is grouped within Diagnostic Related Group(s):
- 642 Inborn and other disorders of metabolism
Applicable To
- Elevated fasting triglycerides
- Endogenous hyperglyceridemia
- Fredrickson’s hyperlipoproteinemia, type IV
- Hyperlipidemia, group B
- Hyperprebetalipoproteinemia
- Very-low-density-lipoprotein-type [VLDL] hyperlipoproteinemia
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E78.1:
- elevated fasting triglycerides > Dyslipidemia E78.5
- fasting triglycerides > Elevated, elevation
- triglycerides > Elevated, elevation
- high > triglycerides E78.9
- IV > Frederickson\’s hyperlipoproteinemia, type
- triglycerides > High
- B > group E78.00
- IV > Fredrickson\’s type E78.3
- very-low-density-lipoprotein-type (VLDL) > Hyperlipoproteinemia E78.5
- hyper-pre-beta > Lipoproteinemia E78.5
- Type IV > hyperlipoproteinemia E78.3